The store will not work correctly when cookies are disabled.
2,4-Dichloro-N-(1-(2-oxo-2-phenylethyl)piperidin-4-yl)benzamide
ID: ALA4070193
PubChem CID: 137638617
Max Phase: Preclinical
Molecular Formula: C20H20Cl2N2O2
Molecular Weight: 391.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CN1CCC(NC(=O)c2ccc(Cl)cc2Cl)CC1)c1ccccc1
Standard InChI: InChI=1S/C20H20Cl2N2O2/c21-15-6-7-17(18(22)12-15)20(26)23-16-8-10-24(11-9-16)13-19(25)14-4-2-1-3-5-14/h1-7,12,16H,8-11,13H2,(H,23,26)
Standard InChI Key: FHULZJDOOVPBCW-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
11.9263 -6.9255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9251 -7.7450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6332 -8.1540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3428 -7.7445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3400 -6.9219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6314 -6.5166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6289 -5.6994 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
11.2171 -8.1530 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.0462 -6.5106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7554 -6.9165 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0431 -5.6934 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.4616 -6.5053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1694 -6.9139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8735 -6.5061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8746 -5.6886 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1655 -5.2805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4553 -5.6899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5823 -5.2800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2900 -5.6886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2900 -6.5058 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.9978 -5.2800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7038 -5.6910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4111 -5.2831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4115 -4.4650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6988 -4.0566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9945 -4.4668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
2 8 1 0
5 9 1 0
9 10 1 0
9 11 2 0
10 12 1 0
12 13 1 0
12 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
15 18 1 0
18 19 1 0
19 20 2 0
19 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 391.30 | Molecular Weight (Monoisotopic): 390.0902 | AlogP: 4.07 | #Rotatable Bonds: 5 |
Polar Surface Area: 49.41 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.53 | CX Basic pKa: 6.32 | CX LogP: 3.51 | CX LogD: 3.48 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.78 | Np Likeness Score: -1.75 |
References
1. Jørgensen L, Al-Khawaja A, Kickinger S, Vogensen SB, Skovgaard-Petersen J, Rosenthal E, Borkar N, Löffler R, Madsen KK, Bräuner-Osborne H, Schousboe A, Ecker GF, Wellendorph P, Clausen RP.. (2017) Structure-Activity Relationship, Pharmacological Characterization, and Molecular Modeling of Noncompetitive Inhibitors of the Betaine/γ-Aminobutyric Acid Transporter 1 (BGT1)., 60 (21): [PMID:28991462] [10.1021/acs.jmedchem.7b00924] |